It is suggested to expand the centralized purchase of traditional Chinese patent medicines and simple preparations to promote the high-quality development of the industry

Due to historical reasons, in the past, pilot enterprises were required to develop over 400 varieties of formula granules. Subsequently, dozens of pilot enterprises approved by various provinces also adopted the previous practice of each having over 400 varieties. With the addition of more enterprises, each producing hundreds of formula granules, while forming a competitive landscape, a scattered situation of industry competition for raw materials, repeated research and development, and repeated production is emerging.

In this context, some drawbacks have also emerged. He stated that due to the variety of raw materials, companies are unable to establish controllable planting bases for raw materials and medicinal herbs in advantageous raw material production areas, which makes it difficult to guarantee the quality of raw materials and causes drastic price fluctuations, affecting the healthy development of the material industry; The research and development of production processes for various types of formula granules is repetitive and wasteful. Developing one variety can cost as little as tens of thousands of yuan, but if there are hundreds of varieties, the investment will reach tens of millions or even billions of yuan. Each enterprise simply repeats research and development, resulting in a great waste of social resources, but lacks the energy to conduct in-depth research; Repeated production by various production enterprises, diverse varieties, and lack of scale have resulted in the inability to adopt advanced technologies, specialized equipment, etc. for each variety, leading to low-level duplication.

The above problems have caused huge waste of manpower, material resources, and medicinal resources, which greatly restricts the healthy development of formula granules. In order to promote the healthy development of the formula granule industry, it is recommended to clarify that formula granules can be circulated as single varieties, and the approval qualifications are not limited by the number of varieties. Encourage enterprises to make one or several formula granule products that they are good at; promote the implementation of centralized procurement of formula granules, allowing single varieties to enter centralized procurement, fully leverage the competitive advantages of specialization, and promote the healthy development of formula granules

Introduction: Centralized purchase of traditional Chinese patent medicines and simple preparations is of great significance for promoting high-quality development of the industry. In the past, for the need of survival and development, traditional Chinese patent medicines and simple preparations enterprises have made great efforts in drug sales. They have a large sales team, and have incurred high sales costs. Some rely on commission rebates to promote sales, increasing the burden. Meanwhile, the elements of high-quality development for enterprises, such as technological innovation and improved enterprise management, have been overlooked. If this continues, it will pose a great threat to the health and sustainable development of the traditional Chinese patent medicines and simple preparations industry.

On the other hand, at present, traditional Chinese patent medicines and simple preparations centralized purchase has just been launched in some provinces and cities, covering less provinces and less varieties of drugs. The Rules for Finalization of Competitive Enterprises in the pilot provinces of traditional Chinese patent medicines and simple preparations centralized purchase differ from each other, but the scores of enterprises' past performance in the technical evaluation link are too high, resulting in insufficient price competition in the bidding process, insufficient performance of centralized purchase with quantity, and failure to put more truly competitive high-quality enterprises at the same level of competition, affecting the overall effect of centralized purchase and the goal of controlling medical insurance costs.

In this regard, the following suggestions are put forward: move ahead and expand the range of traditional Chinese patent medicines and simple preparations's centralized procurement, accelerate the process of traditional Chinese patent medicines and simple preparations's centralized procurement all over the country, realize the large-scale centralized procurement of traditional Chinese patent medicines and simple preparations as soon as possible, boost the high-quality, healthy and sustainable development of the industry, and truly make medicine benefit the Chinese nation. Second, further optimize the traditional Chinese patent medicines and simple preparations centralized purchase rules with quantity, technical evaluation and price competition scoring rules, reduce the weight of technical evaluation, fully reflect the price advantage, and achieve the effect of reducing medical insurance costs and achieving scientific and fair competition on the premise of ensuring drug quality. Thirdly, include formula granules in the scope of centralized procurement to better promote the development of the formula granule industry.

Accelerate the registration and approval process of health food products

In terms of health food, it is reported that through market research, the industry generally reflects that the existing 27 health functions of the country cannot meet the modern health needs of the people, and also lead to serious homogenization of health food in the market, limiting product innovation. In 2019, the government issued the "Management Measures for the Catalogue of Health Food Raw Materials and Health Function Catalogue", which allows research and development entities to conduct research on new raw materials and new functions, but lacks relevant guiding documents and cannot carry out related research work. The quantity and functional categories of domestic health food are far from meeting the public's demand for health.

In this regard, it is recommended to accelerate the registration and approval process for new varieties of health food, and to expedite the approval of newly declared but unapproved health food varieties accumulated over the years, in order to meet the development needs of the health food industry; Publish the health function catalog, functional testing and evaluation technical guidance principles and methods related to health food claims as soon as possible, and improve the registration health food evaluation standards and processes; Establish a research guide and evaluation criteria system for new raw materials and functions of health food as soon as possible, encourage enterprise innovation, create a favorable market development atmosphere, and provide a registration and application channel for research on new raw materials and functions of health food